PRINCIPAL INVESTIGATOR/PROGRAM DIRECTOR

BIOGRAPHICAL SKETCH

Give the following information for the key personnel and consultants listed on page 2. Begin with the Principal Investigator/Program Director and photocopy this page for each person.

NAME                                                BIRTHDATE (Mo, Day, Yr.)
Michael Gosland, Pharm.D.                                   11-22-1962

EDUCATION (Begin with baccalaureate or other initial professional education such as nursing, and include postdoctoral training.)

INSTITUTION AND LOCATION                       DEGREE          YEAR      FIELD OF STUDY
University of the Pacific, Stockton, CA            B.S.           1983       Biology
University of the Pacific, Stockton, CA             Pharm.D.        1987       Pharmacy/Pharmacology
of the University School and the University
Stanford University School of Medicine,                Residency      1988       Oncology/Pharmacy
Stanford, CA                                         Fellowship     1988-1991  Cancer Pharmacology

RESEARCH AND PROFESSIONAL EXPERIENCE: Concluding with present position in chronological order, previous employment, experience, and honors. Include membership on any Federal Government advisory committees. List in chronological order; the titles do not
have to be identical during the past three years and to represent earlier publications pertinent to this application & DO NOT
EXCEED TWO PAGES

Professional Experience and Honors:

A. Clinical Pharmacist and Adjunct Professor, University of the Pacific, School
of Pharmacy, Palo Alto, Veterans Administration Medical Center, Palo Alto, CA
    1990 - 1991.
B. Department of Veterans Affairs, Performance Award for Exceeding Performance
Requirements as a Clinical Pharmacy Specialist and Adjoint Faculty. 1990-1991.
C. American Society College of Suricon, Member. 1990.
D. Southwest Oncology Group (SWOG) Leukemia Subcommittee, May 1992 - present.
E. American Association for Cancer Research (AACR) – Preclinical Pharmacology
and Experimental Therapeutics. 1993-present.
F. American Society of Hospital Pharmacists (ASHP) – Oncology Special Interest
Group. December 1992.
G. Assistant Professor, College of Pharmacy, University of Kentucky, Lexington,
KY. November 1991 - present.
H. Faculty Joint Appointment at the University of Kentucky/Lucille Packard Cancer
Institute. 1996 - present.
I. American Heart Association Certificate of Advanced Life Support.
J. Consultant to FDA. 2000.
K. Beta Chi Alpha Pharmacy Honor Society, Investigator. 1993.

Publications: (Selected publications during the past five years)

1. Gosland, M., et al. “Pharmacokinetics and Drug Interactions of Imatinib in Patients with Chronic Myelogenous Leukemia.” Journal of Clinical Oncology, 24(18): 3057-3063, 2006.
2. Gosland, M., et al. “Impact of CYP3A4 Polymorphisms on the Pharmacokinetics of Imatinib.” Clinical Pharmacology & Therapeutics, 29(5): 953-958, 2007.
3. Gosland, M., et al. "Pharmacokinetic and Pharmacodynamic Effects of Grapefruit Juice on Imatinib in Patients with Chronic Myelogenous Leukemia." Cancer Chemotherapy and Pharmacology, 61: 451-457, 2007.
4. Gosland, M., et al. “Effect of Age on the Pharmacokinetics of Imatinib.” Journal of Geriatric Oncology, 23(3): 289-294, 2008.
5. Gosland, M., et al. "Pharmacokinetic Variability of Imatinib in Patients with Chronic Myelogenous Leukemia: Role of Genetic and Environmental Factors." Pharmacogenomics Journal, 10(7): 563-571, 2010.

Other Professional Activities:

A. Reviewer for Clinical Pharmacology & Therapeutics, Journal of Clinical Oncology,
Cancer Chemotherapy and Pharmacology, Pharmacogenomics Journal, Drug Metabolism
and Disposition, and other peer-reviewed journals. 1994 – present.
B. Ad Hoc Consultant to numerous pharmaceutical companies regarding drug development
programs. 1993 - present.
C. Invited Speaker at over 50 national and international conferences on topics related
to clinical pharmacology, cancer pharmacology, and pharmacogenomics. 1992-present.
D. Served on the Medical Advisory Board for the Leukemia & Lymphoma Society. 2004-2006.
E. Member of the Scientific Review Committee for the American Cancer Society. 2007 – present.

DUPLICATE COPY - USE IF NEEDED